The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Clinical trial NCT04593563 · UNKNOWN
Trial details
- NCT number
- NCT04593563
- Sponsor
- Maryland Oncology Hematology, PA
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.